Menu
×
×

Sign Up

Your Profile will be reviewed by Admin
TODAY :
EVENT DATE
Nov 2017
MoTuWeThFrSaSu
  12345
6789101112
13141516171819
20212223242526
27282930   

Venue

New York Hilton Midtown 1335 Avenue of the Americas New York , New York 10019
Tel: (212) 586-7000
Website
Google Map

VEITHsymposium 2017

1,000 0

Overview

Event Overview:

Now in its 44th year, VEITHsymposium provides vascular surgeons, interventional radiologists, interventional cardiologists and other vascular specialists with a unique and exciting format to learn the most current information about what is new and important in the treatment of vascular disease. The 5-day event features rapid-fire presentations from world renowned vascular specialists with emphasis on the latest advances, changing concepts in diagnosis and management, pressing controversies and new techniques.

Attendee Information:

Objectives

Upon completion of the VEITHsymposium, the participants will, after learning about a wide array of topics, be able to:

Explain the practical implications of clinical trial data on new technologies and techniques for endovascular repair of abdominal aortic aneurysm and thoracic aortic disease
Summarize the impact of data on therapeutic advances for stroke and carotid disease management
Compare the safety, efficacy, and therapeutic indications of pharmacologic agents to the management of vascular disease
Assess data on the latest state-of-the-art for the treatment of superficial femoral and tibial artery disease and describe potential implications for clinical care
Summarize recent data on treatment advances for venous disease and explain their clinical implications
Provide new information about the latest developments in hemodialysis access and vascular malformations and tumors

Exhibitor Information:

VEITHsymposium is a premier educational activity attended by a large and diverse group of vascular specialists throughout the international community. Below are a few reasons why your company should exhibit at this year's VEITHsymposium:

Attendees are eager to learn about the latest new medical technologies for the treatment of vascular disease, clinical trials, and to network with industry professionals
The exhibit hall serves as a forum to launch new, or promote existing medical devices, imaging and/or pharmaceutical products
Interact with a diverse group of decision makers
Collaborate with attendees about new product ideas
Explore merger and acquisition opportunities
Generate exposure for your company and/or product

Agenda

Nov 14   

COMBINED PROGRAM FOR VASCULAR SURGERY, INTERVENTIONAL RADIOLOGY, CARDIOLOGY AND CARDIOTHORACIC SURGERY

6:00AM - General Registration - Rhinelander Gallery, 2nd Floor
6:00AM - Faculty Registration - Morgan Suite - 2nd Floor
6:15AM - Continental Breakfast - Rhinelander Gallery, 2nd Floor

PROGRAMS A, B, C AND D ARE CONCURRENT TUESDAY PROGRAMS

PROGRAM A (SESSIONS 1-8 - PROGRESS IN THE TREATMENT OF HEART VALVE, CORONARY, AORTIC AND CAROTID DISEASES; 6:40 A.M. to 5:52 P.M.)
Location: Grand Ballroom East, 3rd Floor

SESSION 1:

PROGRESS IN THE TREATMENT OF HEART VALVE, CORONARY, AORTIC AND CAROTID DISEASES

SESSION 2:

NEW DEVELOPMENTS IN THE TREATMENT OF AORTIC ARCH LESIONS AND AORTIC DISSECTIONS

SESSION 3:

TYPE B AORTIC DISSECTIONS (TBADs) AND THEIR TREATMENT: THORACIC AND THORACOABDOMINAL ANEURYSMS (TAAAs)

SESSION 4:

MORE NEW DEVELOPMENTS IN THE TREATMENT OF TBADs, THORACIC AORTIC DISEASE, TAAAs AND RELATED TOPICS

SESSION 5:

NEW KEY DEVELOPMENTS IN THE MANAGEMENT OF PATIENTS WITH CAROTID DISEASE

SESSION 6:

NEW DEVELOPMENTS IN THE INVASIVE INTRACRANIAL TREATMENT OF ACUTE STROKES AND RELATED CAROTID AND VERTEBRAL ARTERY TOPICS

SESSION 7:

MORE NEW DEVELOPMENTS IN TBADs, TEVAR AND TAAAs

SESSION 8:

MORE ABOUT TBADs, CONTROVERSIES ABOUT TIMING, INDICATIONS AND VALUE OF TEVAR TREATMENT FOR PATIENTS WITH UNCOMPLICATED TBADs

PROGRAM B (SESSIONS 9-16 - NEW DEVELOPMENTS IN THE TREATMENT OF AAAs (EVAR), AORTIC BRANCH LESIONS (ILIAC, VISCERAL, RENAL); OUTPATIENT AND PRACTICE ISSUES; LAPAROSCOPY, ROBOTICS AND SIMULATION; COMPLEX AAAs; NEW TECHNIQUES AND CONCEPTS AND OPEN OR HYBRID VASCULAR SURGICAL TECHNIQUES; 6:40 A.M. to 5:54 P.M.)
Location: Grand Ballroom West, 3rd Floor

SESSION 9:

NEW DEVELOPMENTS IN THE MANAGEMENT OF AAAs AND EVAR

SESSION 10:

NEW DEVELOPMENTS IN THE TREATMENT OF AORTIC BRANCH LESIONS – ESPECIALLY OF THE AORTO-ILIAC SEGMENT AND THE HYPOGASTRIC ARTERIES

SESSION 11:

NEW DEVELOPMENTS IN VASCULAR LAPAROSCOPY, ROBOTICS AND SIMULATION

SESSION 12:

NEW DEVELOPMENTS IN THE TREATMENT OF JUXTARENAL AND PARARENAL AAAs AND TAAAs

SESSION 13:

OUTPATIENT PRACTICE AND BUSINESS ISSUES

SESSION 14:

NEW ENDOVASCULAR TECHNIQUES, USAGE AND CONCEPTS

SESSION 15:

PROGRESS IN THE TREATMENT OF RENAL AND VISCERAL ARTERY DISEASE

SESSION 16:

TOPICS RELATED TO NEW DEVELOPMENTS IN AORTIC COARCTATION, OPEN SURGICAL AND HYBRID TECHNIQUES

PROGRAM C (SESSIONS 17-18 - MANAGEMENT OF PULMONARY EMBOLISM: A COMPLEX TEAM SPORT; 7:00 A.M. to 12:00 P.M.)
Location: Trianon Ballroom, 3rd Floor

SESSION 17:

MANAGEMENT OF PULMONARY EMBOLISM: A COMPLEX TEAM SPORT - PART 1

SESSION 18:

MANAGEMENT OF PULMONARY EMBOLISM: A COMPLEX TEAM SPORT - PART 2

PROGRAM D (SESSIONS 19-22 - DIAGNOSIS AND TREATMENT OF VASCULAR MALFORMATIONS; 1:00 P.M. to 6:00 P.M.)
Location: Trianon Ballroom, 3rd Floor

SESSION 19:

IMAGING AND PEDIATRIC VASCULAR MALFORMATIONS; LYMPHATIC AND VENOUS MALFORMATIONS

SESSION 20:

SURGICAL ISSUES IN VASCULAR MALFORMATION MANAGEMENT

SESSION 21:

ENDOVASCULAR MANAGEMENT OF HIGH-FLOW VASCULAR MALFORMATION

SESSION 22:

THE WORST COMPLICATION I HAVE EVER HAD AND WHAT I LEARNED (6-MINUTE CASE PRESENTATIONS)

Nov 15   

6:00AM - General Registration - Rhinelander Gallery, 2nd Floor
6:00AM - Faculty Registration - Morgan Suite - 2nd Floor
6:15AM - Continental Breakfast - Rhinelander Gallerly, 2nd Floor

PROGRAMS E, F AND G ARE CONCURRENT WEDNESDAY PROGRAMS

PROGRAM E (SESSIONS 23-30 - PROGRESS IN LOWER EXTREMITY OCCLUSIVE DISEASE AND ITS TREATMENT; 6:40 A.M. to 5:52 P.M.)
Location: Grand Ballroom East, 3rd Floor

SESSION 23:

OCCLUSIVE DISEASE MANAGEMENT – HOT TOPICS, NEW DEVELOPMENTS AND IMPORTANT GENERALITIES

SESSION 24:

MORE ON LOWER EXTREMITY OCCLUSIVE DISEASE – NEW DEVELOPMENTS AND HOT TOPICS RELATING TO STENTS

SESSION 25:

MORE ON COMPLEX LOWER EXTREMITY OCCLUSIVE DISEASE AND ITS TREATMENT – LITHOPLASTY, ATHERECTOMY, TREATMENT FOR CALCIFICATION AND COMBINATIONS OF TREATMENT

SESSION 26:

MORE ON LOWER EXTREMITY OCCLUSIVE DISEASE: NEW DEVELOPMENTS IN DRUG COATED BALLOONS (DCBs), OTHER DEVICES AND BELOW-THE-KNEE (BTK) DISEASE

SESSION 27:

MORE ABOUT CHRONIC LIMB THREATENING ISCHEMIA (CLTI); THE “NO-OPTION FOR TREATMENT” LIMB AND EXTREME LIMB SALVAGE TECHNIQUES AND RESULTS

SESSION 28:

NEW DEVELOPMENTS IN LOWER EXTREMITY STENT-GRAFTS, PROSTHETIC (PTFE) GRAFTS AND TREATMENT FOR IN-STENT RESTENOSIS (ISR)

SESSION 29:

NEW DEVELOPMENTS IN THE TREATMENT OF INTERMITTENT CLAUDICATION (IC) AND ACUTE LIMB ISCHEMIA (ALI)

SESSION 30:

IMPORTANCE OF FOOT ARTERIES AND PERFUSION IN CLTI: HOW TO ASSESS AND TREAT; VALUE OF ANGIOSOMES; METHODS TO EVALUATE EFFECTIVENESS OF TREATMENT

PROGRAM F (SESSIONS 31-38 - NEW DEVELOPMENTS IN MEDICAL, ANTI-ATHEROGENIC AND ANTI-HYPERTENSIVE TREATMENTS; ENDOLEAK MANAGEMENT; ISSUES AND OTHER IMPORTANT TOPICS RELATED TO HISTORY, GOVERNMENT, REIMBURSEMENT, ETHICS, PRACTICE AND VASCULAR CARE; 6:40 A.M. to 6:06 P.M.)
Location: Grand Ballroom West, 3rd Floor

SESSION 31:

MEDICAL TREATMENTS; LIPID MANAGEMENT BY DRUGS; HEART AND CORONARY STENT RELATED TOPICS

SESSION 32:

MEDICAL AND INTERVENTIONAL TREATMENT OF HYPERTENSION; REGENERATIVE TREATMENTS; STENOSIS ASSESSMENT BY FRACTIONAL FLOW RESERVE (FFR); VALUE OF FISH OILS

SESSION 33:

ENDOLEAKS AND ENDOTENSION: THEIR NATURAL HISTORY AND TREATMENT

SESSION 34:

TRIBUTES TO VASCULAR SURGERY GREATS; ISSUES RELATED TO HISTORY, ETHICS, INNOVATION, VASCULAR SURGERY LEADERSHIP, PRACTICE PROBLEMS AND THEIR SOLUTION

SESSION 35:

MORE ISSUES FOR VASCULAR SURGEONS AND VASCULAR SPECIALISTS: THE HEALTH CARE SYSTEM, WHERE IT'S GOING; REIMBURSEMENT, VASCULAR MDs’ HEALTH AND ETHICS

SESSION 36:

FDA; VASCULAR SURGERY’S GOVERNING BODIES, BOARDS, RRCs, EDUCATION AND TRAINING

SESSION 37:

VASCULAR CARE AND ITS VALUE; REIMBURSEMENT; VOLUME AND MALPRACTICE ISSUES

SESSION 38:

ISSUES WITH TRIALS; RCTs; GUIDELINES; STANDARDS; REGISTRIES; QUALITY INITIATIVES; THE SVS AND THE JVS

PROGRAM G (SESSIONS 39-46 - NEW DEVELOPMENTS IN ARCH AND THORACIC AORTIC DISEASE: DISSECTIONS, TAAAs, JUXTA- AND PARARENAL AAAs, PARALLEL GRAFTS, FENESTRATED AND BRANCHED EVAR (F/B/EVAR), MULTILAYER FLOW MODULATING BARE STENTS, AAAs, EVAR AND RECORDED LIVE COMPLEX CASES; 6:50 A.M. to 5:57 P.M.)
Location: Trianon Ballroom, 3rd Floor

SESSION 39:

MORE TOPICS RELATED TO THE THORACIC AORTA, TEVAR, AORTIC DISSECTIONS, TAAAs AND THEIR TREATMENT

SESSION 40:

TREATMENT OF LESIONS OF THE ASCENDING AORTA; THE AORTIC ARCH; PARALLEL GRAFTS; AORTIC DISSECTIONS AND RELATED TOPICS

SESSION 41:

NEW GRAFTS FOR TAAAs; MORE ON JUXTA- AND PARARENAL AAAs; FENESTRATED AND BRANCHED EVAR (F/B/EVAR) AND PARALLEL GRAFTS

SESSION 42:

TREATMENT OF VISCERAL AND RENAL ANEURYSMS, COMPLEX AAAs, TAAAs AND AORTIC DISSECTIONS: MULTILAYER FLOW MODULATING (MLFM) BARE STENTS: PROS AND CONS: 15-YEAR RESULTS OF THE EVAR 2 TRIAL: FUTURE OF EVAR

SESSION 43:

MORE INTERESTING TOPICS RELATED TO THE ABDOMINAL AORTA, AAAs AND EVAR

SESSION 44:

MORE NEW DEVELOPMENTS RELATING TO AAAs AND EVAR

SESSION 45:

CHALLENGING RECORDED LIVE CASES AND THOSE EMPLOYING INNOVATIVE AND NEW TECHNIQUES

SESSION 46:

PIONEERING TECHNIQUES IN PERIPHERAL ARTERY INTERVENTIONS

Nov 16   

6:00AM - General Registration - Rhinelander Gallery, 2nd Floor
6:00AM - Faculty Registration - Morgan Suite - 2nd Floor
6:15AM - Continental Breakfast - Rhinelander Gallery, 2nd Floor

PROGRAMS H, I AND J ARE CONCURRENT THURSDAY PROGRAMS

PROGRAM H (SESSIONS 47-54 - NEW TECHNIQUES, TECHNOLOGY, CONCEPTS; ADVANCES IN F/B/EVAR AND PARALLEL GRAFTS FOR COMPLEX AAAs AND TAAAs; TRIBUTE TO OUR MILITARY; ADVANCES IN MANAGEMENT OF RUPTURED AAAs; NEW DEVELOPMENTS IN ROBOTICS, GUIDANCE AND IMAGING SYSTEMS; RADIATION SAFETY, NEW CONCEPTS AND DEVICES; 6:50 A.M. to 5:54 P.M.)
Location: Grand Ballroom East, 3rd Floor

SESSION 47:

EXCITING NEW OR UPDATED TECHNIQUES, CONCEPTS AND TECHNOLOGIES

SESSION 48:

ADVANCES IN FENESTRATED AND BRANCHED EVAR (F/BEVAR) AND PARALLEL GRAFTS FOR COMPLEX AAAs AND TAAAs; RELATED CONTROVERSIES

SESSION 49:

MORE ABOUT F/B/EVAR AND PARALLEL GRAFTS FOR COMPLEX AAAs AND TAAAs: RELATED TOPICS

SESSION 50:

TRIBUTE TO OUR MILITARY AND SERVICE PHYSICIANS EVERYWHERE; NEW DEVELOPMENTS IN VASCULAR TRAUMA (9-MINUTE TALKS)

SESSION 51:

NEW DEVELOPMENTS IN THE TREATMENT OF RUPTURED AAAs (RAAAs); RELATED CONTROVERSIES

SESSION 52:

MORE RUPTURED ANEURYSM (AAA & TAA) TOPICS AND CONTROVERSIES

SESSION 53:

VASCULAR ROBOTICS; IMAGING SYSTEMS; VIRTUAL REALITY AND GUIDANCE; HYBRID ROOMS

SESSION 54:

RADIATION SAFETY; IMAGING; NEW CONCEPTS AND DEVICES

PROGRAM I (SESSIONS 55-62 - NEW DEVICES FOR EVAR AND COMPLEX AAA REPAIR; TEVAR AND TAAA REPAIR; LOWER EXTREMITY TREATMENT; PREVENTION OF ENDOLEAKS AND MIGRATION (ENDOANCHORS); CLOT REMOVAL AND EMBOLIZATION; 6:40 A.M. to 5:22 P.M.)
Location: Grand Ballroom West, 3rd Floor

SESSION 55:

UPDATE ON NEW DEVICES FOR EVAR AND JUXTA- AND PARARENAL AAAS; AND ILIAC BRANCHED DEVICES (4 ½ MINUTE TALKS)

SESSION 56:

ENDOVASCULAR ANEURYSM SEALING (EVAS) FOR SIMPLE AND COMPLEX AAAs; ASPECTS OF OTHER NEW DEVICES FOR COMPLEX AAAs (4 ½-MINUTE TALKS)

SESSION 57:

NEW DEVICES FOR TREATMENT OF ASCENDING AORTIC AND ARCH LESIONS; TEVAR; Ch/TEVAR AND OTHER MODIFICATIONS OF TEVAR (4 ½ MINUTE TALKS)

SESSION 58:

NEW DEVICES FOR THE TREATMENT OF THORACIC AORTIC LESIONS AND TAAAs (4 ½ MINUTE TALKS)

SESSION 59:

NEW DEVICES FOR TREATING LOWER EXTREMITY ARTERIAL LESIONS: NEW ENDOVASCULAR TREATMENTS, PROSTHETIC GRAFTS, HEPARIN BONDING TO GRAFTS

SESSION 60:

NEW DEVELOPMENTS AND DEVICES FOR LOWER EXTREMITY STENTS, BALLOONS, ATHERECTOMY AND STENT-GRAFTS; TECHNICAL ADVANCES TO IMPROVE THEIR USE

SESSION 61:

NEW DEVICES TO PREVENT AND TREAT ENDOLEAKS AND ENDOGRAFT MIGRATION; ENDOTENSION; ENDOANCHORS (4 ½-MINUTE TALKS)

SESSION 62:

NEW DEVICES FOR EMBOLECTOMY CLOT REMOVAL AND EMBOLIZATION AND THEIR COMPLICATIONS (4 ½ MINUTE TALKS)

PROGRAM J (SESSIONS 63-70 - SUPERFICIAL VENOUS DISEASE; 7:20 A.M. to 5:11 P.M.)
Location: Trianon Ballroom, 3rd Floor

SESSION 63:

VENOUS CLINICAL EXAMINATION AND HEMODYNAMICS

SESSION 64:

VENOUS IMAGING TECHNIQUES

SESSION 65:

SUPERFICIAL VEIN TREATMENT STRATEGIES AND TECHNIQUES

SESSION 66:

VENOUS GOVERNANCE

SESSION 67:

EXAMINING THE EVIDENCE

SESSION 68:

MORE USEFUL SUPERFICIAL VEIN INFORMATION

SESSION 69:

SUPERFICIAL VENOUS ABLATION, COMPRESSION, AND RESEARCH

SESSION 70:

VENOUS PRACTICE MANAGEMENT . . . AND A LITTLE FUN

Nov 17   

6:00AM - General Registration - Rhinelander Gallery - 2nd Floor
6:00AM - Faculty Registration - Morgan Suite - 2nd Floor
6:15AM - Continental Breakfast - Rhinelander Gallery, 2nd Floor

PROGRAMS K, L AND M ARE CONCURRENT FRIDAY PROGRAMS

PROGRAM K (SESSIONS 71-78 - NEW AND IMPROVED OLD TECHNIQUES; CAROTID RELATED TOPICS; NEW DEVELOPMENTS IN SPINAL CORD ISCHEMIA (SCI); UPDATES AND CONTINUING CONTROVERSIES; NEW TECHNIQUES, UPDATES AND CONCEPTS; ADVANCES IN WOUND CARE AND PEVAR; 6:40 A.M. to 6:00 P.M.)
Location: Grand Ballroom East, 3rd Floor

SESSION 71:

NEW AND IMPROVED OLD TECHNIQUES; CAROTID TOPICS RELATED TO RADIATION STENOSIS, RISK ASSESSMENT, COMBINED CAROTID/CORONARY DISEASE AND IMPROVED OPEN TREATMENT TECHNIQUES

SESSION 72:

SPINAL CORD ISCHEMIA (SCI) WITH TREATMENT OF THORACIC ANEURYSMS, TAAAs AND COMPLEX AAAs; NEW DEVELOPMENTS IN PATHOGENESIS PREVENTION AND TREATMENT

SESSION 73:

NEW DEVELOPMENTS IN CAROTID TOPICS RELATED TO RISK FACTORS, CAUSES OF STROKES, COGNITIVE DECLINE, SIGNIFICANCE OF MICROEMBOLI, PATCH CLOSURES AND ANEURYSMS

SESSION 74:

MORE NEW DEVELOPMENTS IN CAROTID TOPICS RELATED TO MEDICAL TREATMENT, PLAQUE CHANGES WITH TREATMENT, CAS/CEA STROKE RISKS, POST CAS ISR AND VERTEBRAL ARTERY DISSECTIONS

SESSION 75:

CAROTID TOPICS RELATED TO IMPROVED DEVICES FOR CAS; MEMBRANE OR MESH COVERED STENTS AND TRANSCAROTID ARTERY REVASCULARIZATION (TCAR)

SESSION 76:

CAROTID TOPICS RELATED TO TRIALS, TIMING OF CEA, CONTROVERSIES, DIFFERING RISKS

SESSION 77:

UPDATES, NEW TECHNIQUES AND CONCEPTS

SESSION 78:

NEW CONCEPTS; UPDATES IN WOUND CARE AND PERCUTANEOUS EVAR (PEVAR) (4 ½-MINUTE TALKS)

PROGRAM L (SESSIONS 79-87 - NEW DEVELOPMENTS IN POPLITEAL ANEURYSMS AND DISEASE; MANAGEMENT OF INFECTED ARTERIES, PROSTHETIC GRAFTS AND ENDOGRAFTS; ADVANCES IN IMAGING, GUIDANCE, HYBRID SUITES, THORACIC OUTLET SYNDROMES, MEDICAL DISEASES AND TREATMENT, VASCULAR TRAUMA TREATMENT AND RADIATION SAFETY; 6:40 A.M. to 5:25 P.M.)
Location: Grand Ballroom West, 3rd Floor

SESSION 79:

NEW DEVELOPMENTS IN POPLITEAL ENTRAPMENTS, ANEURYSMS AND OCCLUSIVE LESIONS AND THEIR TREATMENT

SESSION 80:

NEW DEVELOPMENTS IN THE TREATMENT OF INFECTED ANEURYSMS, PROSTHETIC ARTERIAL GRAFTS AND AORTIC ENDOGRAFTS

SESSION 81:

ADVANCES IN IMAGING, GUIDANCE SYSTEMS, HYBRID SUITES AND FLUOROSCOPY EQUIPMENT

SESSION 82:

ADDITIONAL LOWER EXTREMITY, MEDICAL AND OTHER TOPICS

SESSION 83:

NEW DEVELOPMENTS IN THORACIC OUTLET SYNDROMES (TOSs) AND THEIR TREATMENT

SESSION 84:

NEW DEVELOPMENTS IN THE MANAGEMENT OF VASCULAR TRAUMA AND TAKAYASU’S DISEASE

SESSION 85:

PROGRESS IN THE MEDICAL TREATMENTS OF VASCULAR DISEASE; VASCULAR DISEASES AND RISK PREDICTION

SESSION 86:

INTERESTING TOPICS RELATED TO RADIATION SAFETY, AORTIC OR LOWER EXTREMITY DISEASE

SESSION 87:

RECORDED LIVE CASES OF COMPLEX ENDOVASCULAR AORTIC ANEURYSM TREATMENT FROM MÜNSTER AND THE MAYO CLINIC

PROGRAM M (SESSIONS 88-92 - DEEP VENOUS DISEASE; 7:55 A.M. to 5:06 P.M.
Location: Trianon Ballroom, 3rd Floor

SESSION 88:

PELVIC VENOUS DISORDERS

SESSION 89:

FEMORO-ILIOCAVAL INTERVENTIONAL STRATEGIES TO REDUCE VENOUS HYPERTENSION, HOT IDEAS FOR RECANALIZING CHRONIC TOTAL OCCLUSIONS

SESSION 90:

STRATEGIES FOR CORRECTING SEVERE DEEP VENOUS REFLUX AND/OR OBSTRUCTION, WOUNDS AND NEW HORIZONS FOR VENOUS DISEASE MANAGEMENT

SESSION 91:

STRATEGIES FOR THROMBOEMBOLIC EVENTS IN THE VENOUS SYSTEM INCLUDING THE AXILLO SUBCLAVIAN SYSTEM

SESSION 92:

ENDOVASCULAR AND OPEN SOLUTIONS FOR INFERIOR VENA CAVA TUMORS AND OCCLUSIONS, VENA CAVA FILTRATION STRATEGIES, PITFALLS, AND COMPLICATIONS AND MORE ABOUT ILIAC VEIN STENTING

Nov 18   

6:00AM - General Registration - 2nd Floor Promenade
6:00AM - Faculty Registration - Morgan Suite - 2nd Floor
6:30AM - Continental Breakfast - Grand Ballroom Foyer - 3rd Floor

PROGRAMS N, O AND P ARE CONCURRENT SATURDAY PROGRAMS

PROGRAM N (SESSIONS 93-100 - NEW DEVELOPMENTS AND HOT TOPICS IN THE TREATMENT OF LOWER EXTREMITY, CAROTID AND AORTIC DISEASE; VASCULAR TRAUMA AND KEY MISCELLANEOUS HOT TOPICS; 6:50 A.M. to 4:30 P.M.)
Location: Grand Ballroom East, 3rd Floor

SESSION 93:

LOWER EXTREMITY NEW DEVELOPMENTS AND FAST PACED HOT TOPICS (4 ½-MINUTE TALKS)

SESSION 94:

FAST-PACED NEW DEVELOPMENTS AND HOT TOPICS IN CAROTID DISEASE (4 ½-MINUTE TALKS)

SESSION 95:

NEW DEVELOPMENTS AND HOT TOPICS IN DISEASES OF THE AORTA AND ITS BRANCHES (4 ½- MINUTE TALKS)

SESSION 96:

MISCELLANEOUS HOT TOPICS IN MEDICAL TREATMENT AND VASCULAR DISEASE (4 ½-MINUTE TALKS)

SESSION 97:

MORE FAST-PACED LOWER EXTREMITY HOT TOPICS (4 ½-MINUTE TALKS)

SESSION 98:

MORE FAST-PACED AORTA AND AORTIC BRANCH RELATED TOPICS (4 ½-MINUTE TALKS)

SESSION 99:

MORE FAST-PACED AORTA RELATED HOT TOPICS (4 ½-MINUTE TALKS)

SESSION 100:

FAST-PACED HOT TOPICS RELATED TO TRAUMA AND LOWER EXTREMITY PROCEDURES (4 ½ MINUTE TALKS)

PROGRAM O (SESSIONS 101-105 -NEW DEVELOPMENTS IN VASCULAR ACCESS FOR HEMODIALYSIS; 7:55 A.M. to 4:15 P.M.)
Location: Grand Ballroom West, 3rd Floor

SESSION 101:

IMPORTANT ISSUES IN HEMODIALYSIS ACCESS (7-MINUTE TALKS)

SESSION 102:

OPTIMIZING OUTCOMES IN HEMODIALYSIS ACCESS (7-MINUTE TALKS)

SESSION 103:

POLITICAL, ECONOMIC AND LEGAL ISSUES IN HEMODIALYSIS ACCESS (7 & 15-MINUTE TALKS)

SESSION 104:

NEW TECHNOLOGIES AND CONCEPTS IN HEMODIALYSIS ACCESS (7 MINUTE TALKS)

SESSION 105:

UPDATE ON CLINICAL CHALLENGES IN HEMODIALYSIS ACCESS (7 MINUTE TALKS)

PROGRAM P (SESSIONS 106-109 - MORE HOT VENOUS DISEASETOPICS; 8:00 A.M. to 12:25 P.M.
Location: Trianon Ballroom, 3rd Floor

SESSION 106:

VENOUS IMAGING, THROMBOPHILIA

SESSION 107:

HOW THE EXPERTS WOULD MANAGE RETICULAR AND TELANGIECTASIA: CASE DISCUSSION

SESSION 108:

ASK THE EXPERT

SESSION 109:

DEEP SYSTEM: ATTRACT TRIAL, NEW TECHNOLOGIES, VENOUS STENTING CHALLENGES

Photos +

Videos +

RELATED EVENTS +

MORE events +

Display Makers +